These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32673626)

  • 1. Protein Quality Testing in the Era of Personalized Medicine.
    Doevendans E; Schellekens H
    J Pharm Sci; 2020 Oct; 109(10):2962-2968. PubMed ID: 32673626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development.
    Orubu ESF; Patani BO; Arhewoh MI
    Int J Pharm Compd; 2021; 25(6):475-481. PubMed ID: 34807842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy preparations: Back in the limelight? Pharmacists make up your mind!
    Crommelin DJ; Bouwman-Boer Y
    Int J Pharm; 2016 Nov; 514(1):11-14. PubMed ID: 27863653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the evolution of the pharmaceutical regulatory environment.
    Shafiei N; Ford JL; Morecroft CW; Lisboa PJ; Taylor MJ
    PDA J Pharm Sci Technol; 2013; 67(4):297-306. PubMed ID: 23872441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
    Minghetti P; Pantano D; Gennari CG; Casiraghi A
    Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding with Biotechnology Products, Part 1: General Considerations.
    Allen LV
    Int J Pharm Compd; 2022; 26(5):385-395. PubMed ID: 36053765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of Educational Offerings Provided by Compounding Support Companies in 2019.
    Stevens JT
    Int J Pharm Compd; 2019; 23(3):188-191. PubMed ID: 31085786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria.
    Amadi C; Tsui EK
    Res Social Adm Pharm; 2019 Nov; 15(11):1344-1357. PubMed ID: 30509851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist-industry relationships.
    Saavedra K; O'Connor B; Fugh-Berman A
    Int J Pharm Pract; 2017 Dec; 25(6):401-410. PubMed ID: 28097713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme.
    Robertson J; Walkom E; Moynihan R; Bero L; Henry D
    Int J Pharm Pract; 2010 Apr; 18(2):88-92. PubMed ID: 20441117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safe Use of Recent New Drugs-Current Status and Challenges].
    Ohashi Y
    Yakugaku Zasshi; 2018; 138(2):177-183. PubMed ID: 29386431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Magistral Phage.
    Pirnay JP; Verbeken G; Ceyssens PJ; Huys I; De Vos D; Ameloot C; Fauconnier A
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29415431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.